771583-24-5 Usage
Description
1-[1-(4-FLUOROPHENYL)CYCLOHEXYL]METHANAMINE is a chemical compound with the molecular formula C13H18FN, characterized by its white crystalline appearance. It is an amine derivative known for its psychoactive properties and is primarily utilized as a pharmaceutical intermediate in the synthesis of various drugs and medications. 1-[1-(4-FLUOROPHENYL)CYCLOHEXYL]METHANAMINE is under investigation for its potential therapeutic applications in treating neurological disorders and psychiatric conditions, as well as its possible use in organic chemistry and drug discovery.
Uses
Used in Pharmaceutical Industry:
1-[1-(4-FLUOROPHENYL)CYCLOHEXYL]METHANAMINE is used as a pharmaceutical intermediate for the synthesis of various drugs and medications, leveraging its amine derivative properties to contribute to the development of new therapeutic agents.
Used in Neurological and Psychiatric Applications:
In the field of neurology and psychiatry, 1-[1-(4-FLUOROPHENYL)CYCLOHEXYL]METHANAMINE is being studied for its potential use in the treatment of neurological disorders and psychiatric conditions, due to its psychoactive properties and the ongoing research into its mechanisms of action.
Used in Organic Chemistry and Drug Discovery:
1-[1-(4-FLUOROPHENYL)CYCLOHEXYL]METHANAMINE may also have potential applications in organic chemistry and drug discovery, where its unique structure and properties could contribute to the advancement of chemical research and the development of novel pharmaceutical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 771583-24-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,1,5,8 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 771583-24:
(8*7)+(7*7)+(6*1)+(5*5)+(4*8)+(3*3)+(2*2)+(1*4)=185
185 % 10 = 5
So 771583-24-5 is a valid CAS Registry Number.
771583-24-5Relevant articles and documents
CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS
-
Page/Page column 110, (2010/11/28)
The invention relates to novel cyclohexylamine derivatives and their use in the treatment and/or prevention of central nervous system (CNS) disorders, such as depression, anxiety, schizophrenia and sleep disorder as well as methods for their synthesis. The invention also relates to pharmaceutical compositions containing the compounds of the invention, as well as methods of inhibiting reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine from the synaptic cleft and methods of modulating one or more monoamine transporter.
